References
- The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329(14):977–86
- Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995; 18(2):258–68
- Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28(2):103–17
- Bliss M. The discovery of insulin. Chicago: University of Chicago Press, 1982
- Galloway JA, Chance RE. Improving insulin therapy: achievements and challenges. Horm Metab Res 1994; 26(12):591–8
- White J, Campbell RK. Diabetes mellitus. In: Herfindal ET, Gourley DR, eds. Textbook of therapeutics: drug and disease management. 6th ed. Baltimore: Williams & Wilkins, 1996:357–86
- Santiago J, ed. Medical management of insulin-dependent (type I) diabetes. 2d ed. New York: American Diabetes Assoc, 1994:35–7
- Brange J, Owens DR, Kang S, et al. Monomeric insulins and their experimental and clinical implications. Diabetes Care 1990; 13(9):923–54
- Galloway JA, Chance RE. Approaches to insulin analogues. Diabetes Annual/8 1994:277–97
- Drejer K. The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake. Diabetes Metab Rev 1992; 8(3):259–85
- DiMarchi RD, Chance RE, Long HB, et al. Preparation of an insulin with improved pharmacokinetics relative to human insulin through consideration of structural homology with insulin-like growth factor I. Horm Res 1994; 41(Suppl 2):93–6
- Campbell RK, Campbell LK, White JR. Insulin lispro: review of its role in the treatment of diabetes mellitus. Ann Pharmacother 1996; 30(11):1263–71
- Seigler DE, Olsson GM, Agramonte RF, et al. Pharmacokinetics of long-acting (ultralente) insulin preparations. Diab Nutr Metab 1991; 4:267–73
- Jorgensen S, Vaag A, Langkjaer L, et al. NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue. BMJ 1989; 299(6696):415–9